Navigating FIP: Strategies for Diagnosis & Treatment

This webinar is designed to empower veterinarians with the latest advancements in managing Feline Infectious Peritonitis (FIP), a disease once considered fatal but now treatable due to revolutionary developments in veterinary medicine. With access to compounded antiviral formulations growing worldwide and new research emerging regularly, this session will provide up-to-date treatment protocols and practical guidance tailored to the US context, ensuring veterinarians can confidently manage FIP cases in their practices.

1. Diagnostic approaches to FIP: Gain confidence in diagnosing FIP, using a combination of clinical signs, diagnostic tests, and understanding when to pursue confirmatory methods.
2. Implementation of antiviral treatment protocols: Review the most current antiviral options for FIP available to US veterinarians, including dosages, administration routes, and safety considerations.
3. Evaluating treatment outcomes: Learn how to monitor and assess expected responses to FIP therapy, including recognizing clinical signs of improvement and knowing when to adjust treatment plans.
4. Manage challenging FIP cases: Develop troubleshooting strategies for problematic cases, such as treatment-resistant FIP, managing side effects, and addressing complications during antiviral therapy.

25:50 At what age can a cat develop FIP?
26:48 What clinical signs might support FIP?
30:26 Diagnosis for non-effusive FIP (dry FIP)
34:35 Diagnosis for effusive FIP (wet FIP)
37:48 Using PCR tests for wet FIP
40:48 An alternative approach to Dry FIP diagnosis
42:50 Tests you should not use to diagnose FIP
44:38 Antiviral treatment trials for diagnosis of FIP
50:43 Treatment options for FIP
52:27 GS-441524 vs Molnupiravir / EIDD-1931
52:55 Expected survival with Remdesivir / GS-441524
53:52 GS-441524
54:36 Do FIP cats need corticosteroids?
55:19 Treatment duration (can we do less than 12 weeks?)
59:19 Troubleshooting suboptimal response to GS-441524
1:00:30 Adverse reactions with GS-441524
1:01:26 Molnupiravir / EIDD-1931
1:03:10 Molnupiravir adverse effects
1:03:52 Protease inhibitors
1:06:57 How to decide which antiviral to use?
1:10:45 Q&A

Dr. Sally Coggins graduated with first-class honours from The University of Sydney in 2007. After 2 years in small animal practice in Canberra, Sally commenced work in feline-only practice at The Cat Clinic in Prahran (Melbourne) in 2010, where she remained for 10 years, become a partner and director in this busy practice and seeing a high volume of both first opinion and referral cases. Sally attained her membership qualification in Feline Medicine with the Australian and New Zealand College of Veterinary Scientists in 2012 and went on to become an examiner for the ANZCVS in 2016, 2017, and 2018.

Sally has now turned her attention to research, commencing a full-time master’s under the supervision of Professor Jacqueline Norris, Associate Professor Merran Govendir, and Associate Professor Mary Thompson at the Sydney School of Veterinary Science, The University of Sydney since late 2020. Sally is currently investigating novel antiviral therapeutics for Feline Infectious Peritonitis and is currently conducting clinical trials open for national recruitment. She continues to practice 1 day per week as a feline-only clinician at Gordon Veterinary Hospital, as well as being a feline medicine distance education course tutor for the Centre for Veterinary Education and an undergraduate tutor for Doctor of Veterinary Medicine students at The University of Sydney.